John L. Higgins
2015
In 2015, John L. Higgins earned a total compensation of $4.6M as Chief Executive Officer at Ligand Pharmaceuticals, a 25% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $392,029 |
|---|---|
| Option Awards | $1,810,851 |
| Salary | $547,336 |
| Stock Awards | $1,794,131 |
| Other | $6,369 |
| Total | $4,550,716 |
Higgins received $1.8M in option awards, accounting for 40% of the total pay in 2015.
Higgins also received $392K in non-equity incentive plan, $547.3K in salary, $1.8M in stock awards and $6.4K in other compensation.
Rankings
In 2015, John L. Higgins' compensation ranked 1,826th out of 13,638 executives tracked by ExecPay. In other words, Higgins earned more than 86.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,826 out of 13,638 | 87th |
Division Manufacturing | 660 out of 5,190 | 87th |
Major group Chemicals And Allied Products | 242 out of 1,854 | 87th |
Industry group Drugs | 188 out of 1,528 | 88th |
Industry Pharmaceutical Preparations | 151 out of 1,182 | 87th |
Source: SEC filing on April 14, 2017.
Higgins' colleagues
We found five more compensation records of executives who worked with John L. Higgins at Ligand Pharmaceuticals in 2015.
2015
Matthew Foehr
Ligand Pharmaceuticals
Chief Operating Officer
2015
Matthew Korenberg
Ligand Pharmaceuticals
Chief Financial Officer
2015
Nishan de Silva
Ligand Pharmaceuticals
Chief Financial Officer
2015
Charles Berkman
Ligand Pharmaceuticals
General Counsel
2015
Melanie Herman
Ligand Pharmaceuticals